Prenatal diagnosis and linkage disequilibrium with cystic fibrosis for markers surrounding D7S8 by Dean, M. (Michael Emmans) et al.
Hum Genet (1990) 85 : 275-278 
9 Springer-Verlag 1990 
Prenatal diagnosis and linkage disequilibrium 
with cystic fibrosis for markers surrounding D7S8 
Michael Dean 1, Jean A .Amos  2, Jennifer Lynch 3, Giovanni Romeo 4, Marcella Devoto 4, Ken Ward 5, 
Dicky Halley 6 , Ben Oostra 6 , Maurizio Ferrari 7, Silvia Russo 7 , Bruce S. Weir 8 , Paula B. Finn 2, Francis S. Collins 9 , 
and Michael C. lannuzzi 9 
1Program Resources Inc., Frederick Cancer Research and Development Center, Frederick, MD 21701, USA 
ZBoston University School of Medicine, Boston, MA 02148, USA 
3John Radcliffe Hospital, Oxford OX3 9DU, UK 
4Istituto Giannina Gaslini, 1-16148 Genoa, Italy 
5University of Utah, Salt Lake City, UT 84132, USA 
6Erasmus University, NL-300 DR Rotterdam, The Netherlands 
7 Istituto Scientificio H. S. Raffaele, 1-20132 Milan, Italy 
8North Carolina State University, Raleigh, NC 27695, USA 
9University of Michigan, Ann Arbor, MI 48109, USA 
Received September 27, 1989 !Revised November 21, 1989 
Summary. Three polymorphic DNA markers urround- 
ing the D7S8 locus were tested for their usefulness in the 
diagnosis of cystic fibrosis (CF) by linkage analysis. The 
markers correspond to the loci D7S424 and D7S426. 
These polymorphisms were studied by centers in the 
U.S.,  the United Kingdom, the Netherlands, and Italy, 
using samples from populations throughout Europe and 
North America. The additional information provided by 
these probes increased the heterogeneity of the region 
from 50% to 58% and was essential for a completely in- 
formative diagnosis in one family. A very high degree of 
linkage disequilibrium was found between these mark- 
ers, which span a distance of approximately 250 kb. In 
addition, linkage disequilibrium with CF was noted. Sig- 
nificant heterogeneity of linkage disequilibrium was 
found among the populations, both for the marker-marker 
pairs and between the markers and CF. 
have been used to analyze CF families from several 
countries and ethnic backgrounds. Markers surrounding 
the INTIL1 gene show strong associations, linkage dis- 
equilibrium, with the CF mutation (Beaudet et al. 1986; 
Estivill et al. 1989; Schmidtke t al. 1987). Because the 
CF mutation is often on a haplotype that is infrequent in 
the general population these RFLPs are almost always 
informative in CF families. Relatively few RFLPs have 
been reported near D7S8, and this region shows only 
weak associations with CF (Estivill et al. 1989). 
Using chromsome jumping to isolate new sequences 
a large distance from D7S8, we recently reported the 
identification of several new RFLPs (Iannuzzi et al. 
1989). Our initial data suggested that these new poly- 
morphisms were in strong disequilibrium with D7S8. 
We now report data from several clinical centers on the 
usefulness of these probes to CF families. 
Introduction 
The discovery of linkage between markers on chromo- 
some 7 and cystic fibrosis (CF) made possible carrier de- 
tection and prenatal diagnosis for families with a history 
of the disease (Dean et al. 1985, 1987; Farrall et al. 1986; 
Knowlton et al. 1985; Tsui et al. 1985; Wainwright et al. 
1985; White et al. 1985, 1986; Dean 1988). The CF gene 
is flanked on one side by the MET and INT1L1 genes, 
and on the other by the D7S8 locus (Lathrop et al. 1988; 
Beaudet et al. 1986; Estivill et al. 1989). Restriction 
fragment length polymorphisms (RFLPs) at these loci 
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Materials and methods 
DNA probes were labeled and used for Southern hybridization 
using standard techniques (Southern 1975; Feinberg and Vogel- 
stein 1984). Standardized linkage disequilibrium was calculated as 
described (Iannuzzi et al. 1989; Hill and Robertson 1968). Tests 
for homogeneity of linkage disequilibrium were performed as de- 
scribed (Laurie-Ahlberg and Weir 1979; Weir 1990). 
Results 
Three previously reported RFLPs at the W32 (D7S424), 
and J29 (D7S426) locus were used by seven centers to 
type families requesting enetic diagnosis. W32 detects a
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Table l. Frequency of D7S8 region restriction fragment length polymorphisms (RFLPs) 
Center a W32 SacI, D7S8MspI ,  J29PvuII,  J29EcoRV,  
allele allele allele allele 
1 2 n 1 2 n 1 2 n 1 2 n 
ROT 0.39 0.61 113 0.46 0.54 142 0.48 0.52 109 0.48 0.52 105 
OXF 0.34 0.66 99 0.41 0.59 99 0.37 0.63 98 0.43 0.57 98 
BOS 0.39 0.61 142 0.40 0.60 144 0.39 0.61 142 0.42 0.58 145 
SLR 0.40 0.60 103 0.53 0.47 118 0.45 0.55 95 0.46 0.54 50 
SLC 0.41 0.59 98 0.45 0.55 104 0.42 0.58 102 - - - 
MI 0.40 0.60 297 0.51 0.49 181 0.19 0.71 16 0.31 0.69 16 
GE 0.53 0.47 36 0.38 0.62 239 0.44 0.56 100 - - - 
Total 0.40 0.60 888 0.45 0.55 1027 0.41 0.59 662 0.44 0.56 414 
a Centers are: ROT, Rotterdam; OXF, Oxford; BOS, Boston; SLR and SLC, Salt Lake City reference and clinical families; MI, Milan; 
GE, Genoa 
Table 2. Linkage disequilibrium values for marker-marker pairs a
SacI- Msp I b SacI- PvuI I b SacI- Eco R V Msp I- PvuII b Msp I- Eco R V b PvuI I- Eco R V 
A Z 2 n A ~2 n k ~2 n k Z 2 n k Z 2 n A Z 2 n 
MI 0.67 64 145 . . . . . . . . . . . . . . .  
GE 1.0 28 28 0.62 12 32 - - - 0.76 55 94 . . . . . .  
ROT 0.81 80 105 0.92 69 81 0.85 64 89 0.92 86 101 0.96 93 101 0.90 62 77 
OXF 0.83 57 87 0.89 69 86 0.79 54 87 0.70 42 86 0.78 53 87 0.88 67 86 
UTR 0.72 44 84 0.90 62 77 - - - 0.69 39 81 . . . . . .  
UTC 0.88 76 98 0.94 86 98 - - - 0.90 79 98 . . . . . .  
BOS 0.73 76 141 0.83 96 139 0.80 89 141 0.65 65 142 0.64 59 144 0.87 108 142 
Total 688 507 0.81 207 317 602 341 0.88 235 305 
a Probes used were as follows: SacI, W32 (D7S424); MspI, pJ3.11 (D7S8); PvufI and EcoRV,  J29 (D7S426) 
b These populations showed significant heterogeneity forlinkage disequilibrium and were not totaled 
MET A C A C A C 
XV2CIKM19 A A A A A A 
CF +/-  +/ -  - / -  
W32 1 2 1 2 1 2 
D7S8 N O N O N 0 
J29 Pvu 1 2 1 2 1 2 
Eco RV 211 2/2 1/2 
Fig. 1. Cystic fibrosis (CF) family informative for the J29 EcoRV 
polymorphism. Shown are the parents (half-filled) and CF child 
(filled) and the genotypes for several RFLPs. The mother is het- 
erozygous for J29 EcoRV,  whereas the father is homozygous. This 
allows the mother's CF and normal chromosomes to be followed 
Sac I  RFLP  and is 60kb centromeric to D7S8; J29 de- 
tects EcoRV and Pvu I I  polymorphisms and is 150kb 
telomeric to D7S8 ( Iannuzzi  et al. 1989). The majority 
of families were nuclear, comprising both parents and 
one affected child. In total 306 families were studied, al- 
though each marker  was not typed in every individual. 
The frequency of the RFLPs were not significantly 
different (at the 5% level) between the study groups 
(Table 1). These new markers increased the heterozy- 
gosity of the D7S8 side of the gene from 50% to 58%, al- 
lowing a greater percentage of families to be informa- 
tive. To examine the extent of l inkage disequil ibrium (A) 
between these markers and D7S8, haplotypes were gen- 
erated. All marker-marker  pairs showed strong associa- 
tion in all the populat ions tudied, with standardized 
l inkage disequil ibrium values ranging from 0.62 to 1.0 
(Table 2). However,  a statistically significant degree of 
heterogeneity over populat ions was found for marker 
pairs (data not shown). No correlation was found be- 
tween the extent of disequil ibrium and the distance be- 
tween the probes. By analyzing haplotypes we found 
that only 11 of 16 possible haplotypes were present in 
149 CF chromosomes, with two haplotypes (1-1-1-1, 2-2- 
2-2) comprising 83% of the sample. On normal  chromo- 
somes, 12 haplotypes were found out of 145 chromo- 
somes, with the same two haplotypes accounting for 
85% of the total. Thus there is a significant distortion in 
the distribution of haplotypes in this region. 
Despite the modest increase in heterozygosity ob- 
served with these new probes, use has been made of the 
Table 3. Linkage disequilibrium with the cystic fibrosis locus" 
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SacI b MspI b PvuII EcoRV b 
A Z 2 n A Z 2 n A Z 2 n A %2 n 
MI 0.07 1.2 251 -0.09 1.2 145 . . . . . .  
GE -0.17 1.0 36 0.15 2.1 94 0 0 100 - - - 
ROT -0.23 5.5 105 -0.31 5.8 129 -0.34 11 101 -0.27 7.3 101 
UTR -0.10 0.9 95 -0.01 0 105 -0.05 0.2 92 - - - 
OXF -0.12 1.2 87 -0.11 1.0 87 -0.13 1.5 86 -0.13 1.5 87 
BOS -0.29 12 141 -0.30 13 144 -0.23 7.6 142 0.20 6 144 
UTC -0.18 3.2 98 -0.13 1.7 98 -0.15 2.5 98 - - - 
Total 811 802 -0.16 16 637 334 
a Probes used: SacI, W32 (D7S424); MspI, pJ3.11 (D7S8); PvuII and EcoRV, J29 (D7S426) 
b Populations heterogeneous forlinkage disequilibrium 
J29 EcoRV RFLP to achieve a fully informative diag- 
nosis in one case. Here both parents and the affected 
child were heterozygous for several markers commonly 
used for prenatal diagnosis (Fig. 1), thus marking it im- 
possible to distinguish an affected from an unaffected 
fetus. The EcoRV RFLP was informative only in the 
mother, which allowed the maternal CF chromosome to 
be traced in the fetal DNA,  and by combining this mark- 
er with the others, a prediction can be made from all 
possible genotypes. 
Low, but significant, values of linkage disequilibrium 
with CF have been reported for D7S8 (Estivill et al. 
1989; Schmidtke t al. 1987), and most of the centers in 
this study showed low A values for markers in this region 
and CF (Table 3). Significant heterogeneity over popula- 
tions was found for associations of CF with all markers 
except for the J29 PvuII RFLP. Two of the centers (BOS, 
ROT) show strikingly higher values than all the others. 
Both of these centers received patients from a dispersed 
area with no obvious concentration of any one geograph- 
ical region. The BOS families were taken from all over 
North America, and the ROT sample includes families 
from several European countries ( J .A. Amos, D.Hal -  
ley, and B. Oostra, data not shown). Because all of the 
patients are Caucasians of European origin this discrep- 
ancy is hard to explain. 
Due to the strong linkage disequilibrium exhibited 
between these new markers and D7S8, the RFLPs stud- 
ied here will not be useful as primary markers for the 
analysis of CF families. These markers could certainly be 
used in the place of D7S8, and in the hands of some 
groups gave clearer esults. However,  as shown in Fig. 1, 
these probes do provide additional information in cer- 
tain cases. We estimate that 16% of individuals unifor- 
mative for D7S8 will be informative with one of these 
polymorphisms. 
Discussion 
Following the discovery of linkage between an RFLP 
marker and a disease gene, the next step is to identify 
markers flanking the gene, and further closely linked, 
highly polymorphic RFLPs. The rationale behind this 
strategy is to increase the applicability of genetic testing 
and pedigree analysis. With flanking markers, each 10 
cM from the disease gene, a fully informative family can 
be diagnosed with an accuracy approaching 96%. Locus 
expansion, (isolating additional sequences flanking a 
marker using chromosome walking) usually results in the 
identification of additional polymorphisms, which in- 
crease the heterozygosity of the locus. For example, this 
strategy was used to increase the informativeness of 
markers linked to Huntington's chorea (Gilliam et al. 
1987). However, as reported here, large regions of DNA 
in linkage disequilibrium may frustrate such efforts. 
While the sequences surrounding D7S8 may not be typi- 
cal of most loci, only a small portion of the human geno- 
me has been examined in this fashion, making it hard to 
predict the extent of disequilibrium in other regions. 
Rommens et al. (1989) have found a similar large stretch 
of DNA in disequilibrium between the INTIL1 gene and 
CF. Large regions of DNA in disequilibrium are more 
likely to occur for diseases like CF, which are restricted 
to specific racial groups, and have a low mutation rate. 
On the other hand, the presence of large regions in dis- 
equilibrium would aid the analysis of complex diseases 
that involve both genetic and environmental factors, and 
may require population genetics approaches. 
The range of associations between D7S8 and CF in 
the different centers was surprising, given that almost all 
the families are Caucasian. This difference can be most 
likely explained by either the presence of actual differ- 
ences in the populations or an artefact of the sample 
size. Since both the BOS and ROT populations are quite 
heterogeneous, the difference is most likely due to sam- 
ple size. These two centers studied 42 and 35 families, 
respectively. 
While this manuscript was in preparation the cloning 
of the CF gene, and the identification of a mutation pre- 
sent on 70% of CF chromosomes was described (Rom- 
mens et al. 1989; Riordan et al. 1989). Presumably the 
remaining mutations will be identified, and the diagnosis 
of CF will involve the direct identification of mutations. 
In this case the markers described here will no longer be 
of use in prenatal diagnosis. However, the approaches 
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and problems described will apply to the diagnosis of 
other genetic diseases as they progress from linkage to 
the identif ication of mutat ions.  
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